Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation

Lignende værker

• Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors
  af: Marampon, Francesco, et al.
  Udgivet: (2006)
• p21(WAF1 )expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells
  af: Ciccarelli, Carmela, et al.
  Udgivet: (2005)
• Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
  af: Ciccarelli, Carmela, et al.
  Udgivet: (2016)
• Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
  af: Gravina, Giovanni L, et al.
  Udgivet: (2010)
• Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma
  af: Yang, Sufang, et al.
  Udgivet: (2017)